Fig. 1 · Structure

Documents & Downloads

Ibandronate Sodium

Cat. No. A31471 CAS 138844-81-2

FPP synthase Inhibitor

Ibandronate Sodium is a specific inhibitor of farnesyl pyrophosphate synthase (FPP synthase), functioning primarily through the inhibition of the mevalonate pathway. This compound effectively disrupts isoprenylation of small GTPases, including RAS and RHO family proteins, leading to tumor cell apoptosis and decreased bone resorption. Ibandronate Sodium has demonstrated the ability to hinder ER+ breast cancer cell proliferation, increase expression of the pro-apoptotic gene FAS, and exhibit synergistic anti-tumor effects with anti-estrogen agents. Its applications extend to investigating osteoporosis and the mechanisms underlying bone metastasis in tumors, particularly those involving breast cancer.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 138844-81-2
Applications FPP synthase Inhibitor
Formula C9H22NNaO7P2
Molecular Weight 341.21
SMILES
OC(P(O)(O)=O)(P(O)([O-])=O)CCN(C)CCCCC.[Na+]

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...